Mursla Bio
Developer of a non-invasive diagnostic platform designed for early detection of cancer. The company's platform applies extracellular vesicle science and omics analysis, incorporating organ-specific ve...
Valuation
$53.2M
Market implied
Share Price
N/A
Total Raised
$10.2M
Last Round
N/A